Schizophrenia News

Genetic predisposition for schizophrenia and frequent use of cannabis both independently corresponded with an increased likelihood of developing psychosis, results of a case-control study showed.

Genetically predicted major depression may present in women, but not men, with increased risk for arrhythmia disorders, coronary artery disease and heart failure, and risk may vary based on menopausal status, researchers reported.

Individuals who visited the ED for hallucinogen use had a greater risk for developing a schizophrenia spectrum disorder compared with the general population and ED visits for other substances, researchers found.

Two FDA committees overwhelmingly voted to strike down monitoring requirements under a Risk Evaluation and Mitigation Strategy, or REMS, program for clozapine, a medication for individuals with treatment-resistant schizophrenia.

Individuals with a predelivery history of concussion appeared to be at increased risk for severe maternal mental illness, highlighting the importance of screening and supportive care for this high-risk group, according to researchers.

SAN ANTONIO —An intestinal microsomal triglyceride transfer protein inhibitor reduced postprandial triglycerides and halted weight gain in patients treated with the antipsychotic olanzapine, according to results of a pilot study.

According to published results, severe mental illnesses, such as schizophrenia and bipolar disorder, may be risk factors for decreased bone mineral density, fragility fractures and undiagnosed osteoporosis.

Antipsychotics differed in their efficacy in preventing relapse hospitalization and treatment failure among patients with schizophrenia spectrum disorder, according to research published in JAMA Network Open.

Adults with a schizophrenia spectrum disorder had increased risk for severe infection outcomes while exposed to antipsychotics compared with nonexposure periods, according to a study published in The Lancet Psychiatry.